References
- Denis J. Antiviral chemotherapy in ophthalmology. Antiviral Drugs. Basic and Therapeutic Aspects, R. Calio, G. Nistigo. Pythagora Press, RomeItalie 1989; 39–46
- Coleman V. R., Tsu E., Jawetz F. “Treatment-Resistance” to idoxuridine in herpetic keratitis. Soc. Exp. Biol. Med. 1968; 120: 761–765
- Field J. H. Review. Persistent herpes simplex virus infection and mechanisms of virus drug resistance. Eur. J. Clin. Microbiol. Infect. Dis. 1989; 8: 671–680
- Denis J., Langlois M., Elkaim M., Amiel C., Aymard M., Huraux J. M. HSV1 strain sensitivity in experimental rabbit keratitis : evolution under repeated topical administrations. Curr. Eye Res. 1987; 6: 39–45
- Simpson P. R., Chamberlain J. Choice of screening tests. J. Epidemiol. Comm. Health 1978; 12: 166–170
- Langlois M., Allard J. P., Nugier F., Aymard M. A rapid and automated colorimetric assay for evaluating the sensitivity of herpes simplex strains to antiviral drugs. J. Biol. Stand 1986; 14: 201–211
- Nugier F., Langlois M., Aymard M., Colin J. N. Occurence and characterization of acyclovir-resistant herpes simplex virus isolates. Report of two years sensitivity screening survey. 1990, (unpublished observation)
- Klemperer H. G., Haynes G. R., Shedden W. I.H., Watson D. H. A virus specific thymidine kinase in BHK 21 cells infected with herpes simplex virus. Virology 1967; 31: 120–128
- Martin J. L., Ellis M. N., Keller P. M., Biron K. K., Lehrman S. N., Barry D. W., Furman P. A. Plaque autoradiography assay for the detection and quantitation of thymidine kinase-deficient and thymidine kinase-altered mutants of herpes simplex virus in clinical isolates. Antimicrob. Agents Chemother. 1985; 28: 181–187
- McLaren C. Drug resistance patterns of herpes simplex virus isolates from patients treated with acyclovir. Antimicrob. Agents Chemother. 1985; 28: 740–744
- Charles S. J., Gray J. J. Ocular herpes simplex virus infections: reduced sensitivity to acyclovir in primary disease. Br. J. Ophthalmol. 1990; 74: 286–288
- Yoshida T., Suzutani T., Azuma M. Study on the apparent resistant strains of herpes simplex virus type 1 against 9-β-D-Arabinofuranosyladenine. Tohoku J. Exp. Med. 1988; 156: 279–290
- Prusoff W. H., Fisher P. H. Basis for the selective antiviral and antitumour activity of pyrimidine nucleoside analogues. Nucleoside Analogues Chemistry, Biology, and Medical Applications, R. T. Walker, E. De Clercq, F. Eckstein. Plenum Press, New York 1979; 101–102
- Larder B. A., Darby G. Susceptibility to other antiherpes drugs of pathogenic variants of herpes simplex virus selected for resistance to acyclovir. Antimicrob. Agents Chemother. 1986; 29: 894–898